Navigation Links
JHP Pharmaceuticals Enters Agreement to Produce Unique Late Stage Ophthalmic Product
Date:9/16/2013

PARSIPPANY, N.J., Sept. 16, 2013 /PRNewswire/ -- JHP Pharmaceuticals, a leading provider of global contract manufacturing services for sterile products, is pleased to announce that it has entered into a manufacturing agreement with an undisclosed pharmaceutical company which has developed proprietary products that provide sustained and localized drug concentration. The agreement is for technical transfer, registration batch manufacture and commercial supply of a unique late stage ophthalmic product.

JHP's manufacturing expertise and cGMP compliance history were critical factors in the selection process. Stuart Hinchen, President and CEO stated, "This important product has critical manufacturing requirements. We have successfully manufactured and filled a number of different products over the past few years, all with unique parameters. Our experience in this area provides our customers with a sound resource as the product moves through launch and commercialization. Our record of cGMP compliance driven by experienced quality and regulatory teams continues to be one of the key reasons customers chose JHP." 

Hinchen noted, "JHP is now expanding its manufacturing capabilities by introducing a new ophthalmic filling line that will further enhance production effectiveness. This innovative equipment will offer a disposable filling circuit, reduced line losses and broader product handling capabilities all in a restricted access configuration. At the moment, the new filling line is under construction and is expected to be fully operational during the second half of 2014."

JHP Pharmaceuticals, located in Rochester, Michigan, has over 27 years' experience in contract manufacturing. It has developed many partnerships in its history manufacturing clinical and commercial products. JHP has successfully supported launches of several products in US and international markets. Currently it manufactures products for sale in 86 countries. 

About JHP Pharmaceuticals, LLCJHP Pharmaceuticals, headquartered in New Jersey, provides contract manufacturing of sterile products including biologics, small molecule, controlled substances, vaccines, ophthalmics, otics and antibiotics for large and small pharmaceutical and biotech organizations.

JHP's sterile manufacturing facility, located in Rochester Michigan sits on over 85 acres of land and includes a 171,000 sq. ft. production building and warehouse.  The production facility utilizes three high-speed filling lines, a clinical filling line, an ophthalmic filling line and four lyophilizers.  The site includes a new, innovatively-designed facility for chemistry, sterility testing and analytical methods development. 

JHP has the capability to manufacture small-scale clinical through large-scale commercial products.  JHP employs more than 400 staff in the USA in its manufacturing, product development, regulatory, sales and marketing and corporate areas.  For more information, please visit www.jhppharma.com.Contact:Dan Leone 973.658.3559Bill Conway  877.906.7556 jhpcontractservices@jhppharma.com MK513 


'/>"/>
SOURCE JHP Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Actinium Pharmaceuticals Appoints Kaushik J. Dave, Ph.D., MBA As President, Chief Executive Officer And Director
2. Frost & Sullivan Lauds Adcock Ingrams Capability to Innovatively Cater to the Dynamic Needs of Emerging Pharmaceuticals Markets
3. Dr. David Hangauer, Chief Scientific Officer and Co-Founder, commits his career to Kinex Pharmaceuticals
4. Access Pharmaceuticals Awarded Second European Patent for MuGard
5. Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., As Chief Medical Officer
6. Caldera Pharmaceuticals Announces Closing of Financing
7. HedgePath Pharmaceuticals Enters into Key Collaboration with Mayne Pharma
8. Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
9. Roche and Inovio Pharmaceuticals partner on Inovios prostate cancer and hepatitis B immunotherapy products
10. UHC to Launch New Specialty Pharmacy Program for Better Continuity of Patient Care, Improved Access to Specialty Pharmaceuticals
11. DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals Establish Clinical Advisory Board in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... http://www.rebound-solution.com/ ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... PurhealthRX , a leading Health and Nutrition Company, is announcing the ... spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the amount ... into liquid products, while reducing costs to end users. , The team of researchers ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
Breaking Medicine News(10 mins):